Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 17 Stomach Neoplasms 5 Rectal Neoplasms 2 Colonic Neoplasms 2 Advanced Colorectal Carcinoma 2 Unresectable Metastatic Colorectal Cancer 1 TAS 102 1 Sarcoma 1 Patients With Advanced Metastatic Colorectal Cancer 1 Pancreatic Neoplasms 1 Metastasis Colorectal Cancer 1 Locally Advanced Rectal Cancer 1 HER2-positive Gastric Cancer 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Adenocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Biliary Tract Adenocarcinoma 1 Advanced Pancreatic Carcinoma 1

Interventions

Doxorubicin 19 Radiotherapy 10 Ifosfamide 10 apatinib 9 anlotinib 8 Cyclophosphamide 8 camrelizumab 7 Vincristine 5 Dactinomycin 5 toripalimab 3 Trabectedin 3 Radiation Dose Hypofractionation 3 Etoposide 3 Docetaxel 3 ribociclib 2 brostallicin 2 Topotecan 2 Thalidomide 2 Temozolomide 2 Sorafenib 2 Oncolytic Virotherapy 2 Nivolumab 2 Neoadjuvant Therapy 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Gene Expression Profiling 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma × HMPL-013 × Clear all

NCT05142631 2022-03-02

Fruquintinib in the Treatment of Soft Tissue Sarcoma

Fudan University

Phase 2 Unknown

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡